Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
27 07 2021
Historique:
received: 22 12 2020
revised: 01 04 2021
accepted: 08 04 2021
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Coronary artery bypass grafting (CABG) was introduced in the 1960s as the first procedure for direct coronary artery revascularization and rapidly became one of the most common surgical procedures worldwide, with an overall total of more than 20 million operations performed. CABG continues to be the most common cardiac surgical procedure performed and has been one of the most carefully studied therapies. Best CABG techniques, optimal bypass conduits, and appropriate patient selection have been rigorously tested in landmark clinical trials, some of which have resolved controversy and most of which have stoked further debate and trials. The evolution of CABG cannot be properly portrayed without presenting it in the context of the parallel development of percutaneous coronary intervention. In this Historical Perspective, we a provide a broad overview of the history of coronary revascularization with a focus on the foundations, evolution, best evidence, and future directions of CABG.

Identifiants

pubmed: 34294272
pii: S0735-1097(21)05185-8
doi: 10.1016/j.jacc.2021.04.099
pii:
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

365-383

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Michael J Mack (MJ)

Baylor Scott & White Health, Dallas, Texas, USA. Electronic address: michael.mack@bswhealth.org.

John J Squiers (JJ)

Baylor Scott & White Health, Dallas, Texas, USA.

Bruce W Lytle (BW)

Baylor Scott & White Health, Dallas, Texas, USA.

J Michael DiMaio (JM)

Baylor Scott & White Health, Dallas, Texas, USA.

Friedrich W Mohr (FW)

Leipzig Heart Center, Leipzig Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH